Costa Verde Capital Overview
- Investor Type
-
Venture Capital
- Status
-
Inactive
- Investments
-
3
- Exits
-
1
Costa Verde Capital General Information
Company Description
Costa Verde Capital was a venture capital firm based in New York, New York. It used to invest in the healthcare sector.
Business Details
Investor Status
Primary Investor Type
Corporate Office
- 222 West 14th Street
- Suite 3L
- New York, NY 10011
- United States
Costa Verde Capital Investments (3)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Auspex Pharmaceuticals | 20-Dec-2013 | Later Stage VC | Drug Discovery | Clinical Trials - Phase 3 | ||
| Auspex Pharmaceuticals | 06-May-2008 | Drug Discovery | Clinical Trials - Phase 3 | |||
| Auspex Pharmaceuticals | 01-May-2006 | Drug Discovery | Clinical Trials - Phase 3 |
Costa Verde Capital Exits (1)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Auspex Pharmaceuticals | 05-Feb-2014 |
Costa Verde Capital Investments by Industry, Year, and Region
Costa Verde Capital FAQs
-
What is Costa Verde Capital?
Costa Verde Capital was a venture capital firm based in New York, New York.
-
Where is Costa Verde Capital headquartered?
Costa Verde Capital is headquartered in New York, NY.
-
How many investments has Costa Verde Capital made?
Costa Verde Capital has made 3 investments.
-
What has Costa Verde Capital invested in?
Costa Verde Capital has invested in Auspex Pharmaceuticals within the Drug Discovery industry.
-
What has Costa Verde Capital invested in recently?
Costa Verde Capital's latest investment was on 20-Dec-2013 in Auspex Pharmaceuticals, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process